Literature DB >> 19190362

Megavoltage image contrast with low-atomic number target materials and amorphous silicon electronic portal imagers.

E J Orton1, J L Robar.   

Abstract

Low-atomic number (Z) targets have been shown to improve contrast in megavoltage (MV) images when using film-screen detection systems. This research aims to quantify the effect of low-Z targets on MV image contrast using an amorphous silicon electronic portal image detector (a-Si EPID) through both experimental measurement and Monte Carlo (MC) simulation. Experimental beams were produced with the linac running in the 6 MeV electron mode and with a 1.0 cm aluminum (Al, Z = 13) target replacing flattening filtration in the carousel, (6 MeV/Al). A 2100EX Varian linac equipped with an aS500 EPID was used with the QC3 MV phantom for the majority of contrast measurements. The BEAMnrc/EGSnrc MC package was used to build a model of the full imaging system including beam generation (linac head), the a-Si detector and the contrast phantom. The model accurately reproduces contrast measurements to within 2.5% for both the standard 6 MV therapy beam and the 6 MeV/Al beam. The contrast advantage of 6 MeV/Al over 6 MV, as quantified with the QC3 phantom, ranged from a factor increase of 1.6 +/- 0.1 to 2.8 +/- 0.2. Only a modest improvement in contrast was seen when the incident electron energy was reduced to 4 MeV (up to factor of 1.2 +/- 0.1 over 6 MeV/Al) or with removal of the copper build-up layer in the detector, (up to factor of 1.2 +/- 0.1 over 6 MeV/Al). Further decreasing the target Z, to beryllium (Be, Z = 4), at 4 MeV showed no significant improvement over 4 MeV/Al. Experimentally, the contrast advantage of 6 MeV/Al over 6 MV was found to decrease with increasing patient thickness, as can be expected due to selective attenuation of low-energy photons. At head and neck-like thicknesses, the low-Z advantage is a factor increase of 1.7 +/- 0.1.

Entities:  

Mesh:

Year:  2009        PMID: 19190362     DOI: 10.1088/0031-9155/54/5/012

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  7 in total

1.  Low Z target switching to increase tumor endothelial cell dose enhancement during gold nanoparticle-aided radiation therapy.

Authors:  Ross I Berbeco; Alexandre Detappe; Panogiotis Tsiamas; David Parsons; Mammo Yewondwossen; James Robar
Journal:  Med Phys       Date:  2016-01       Impact factor: 4.071

2.  Investigation of the use of external aluminium targets for portal imaging in a medical accelerator using Geant4 Monte Carlo simulation.

Authors:  Hyungdong Kim; Byungyong Kim; Jonggeun Baek; Youngkee Oh; Sangmo Yun; Hyunsoo Jang
Journal:  Br J Radiol       Date:  2018-02-06       Impact factor: 3.039

3.  Automatic x-ray image contrast enhancement based on parameter auto-optimization.

Authors:  Jianfeng Qiu; H Harold Li; Tiezhi Zhang; Fangfang Ma; Deshan Yang
Journal:  J Appl Clin Med Phys       Date:  2017-09-06       Impact factor: 2.102

4.  Investigation of planar image quality for a novel 2.5 MV diamond target beam from a radiotherapy linear accelerator.

Authors:  Jennifer M Borsavage; Amanda Cherpak; James L Robar
Journal:  Phys Imaging Radiat Oncol       Date:  2020-11-05

5.  Characterization and evaluation of 2.5 MV electronic portal imaging for accurate localization of intra- and extracranial stereotactic radiosurgery.

Authors:  Kwang Hyun Song; Karen Chin Snyder; Jinkoo Kim; Haisen Li; Wen Ning; Robert Rusnac; Paul Jackson; James Gordon; Salim M Siddiqui; Indrin J Chetty
Journal:  J Appl Clin Med Phys       Date:  2016-07-08       Impact factor: 2.102

6.  Characterization of a 2.5 MV inline portal imaging beam.

Authors:  James L Gräfe; Jennifer Owen; J Eduardo Villarreal-Barajas; Rao F H Khan
Journal:  J Appl Clin Med Phys       Date:  2016-09-08       Impact factor: 2.102

7.  Low-dose 2.5 MV cone-beam computed tomography with thick CsI flat-panel imager.

Authors:  Grace Tang; Christopher Moussot; Daniel Morf; Edward Seppi; Howard Amols
Journal:  J Appl Clin Med Phys       Date:  2016-07-08       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.